Scholars@Duke
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel
Carey Kernodle Anders

Carey Kernodle Anders

Professor of Medicine
Medicine, Medical Oncology
carey.anders@duke.edu
Box 3381, Seeley Mudd Building, Durham, NC 27710
Dept of Medicine, Durham, NC 27710

Selected Publications

Real-world treatment patterns and clinical outcomes with tucatinib-based therapy in patients with HER2-positive metastatic breast cancer: analyses of two nationwide administrative health claims databases.

Journal Article Int J Clin Oncol · October 2025 PURPOSE: To describe real-world characteristics and clinical outcomes among patients with HER2+ MBC receiving tucatinib-based treatments. METHODS: This retrospective study included patients diagnosed with HER2+ MBC between January 2017 and December 2022 fr ... Full text Link to item Cite

Genomic and immune profiling of breast cancer brain metastases.

Journal Article Acta neuropathologica communications · May 2025 BackgroundBrain metastases (BrM) arising from breast cancer (BC) are an increasing consequence of advanced disease, with up to half of patients with metastatic HER2 + or triple negative BC experiencing central nervous system (CNS) recurrence. The ... Full text Cite

Triple Negative Breast Cancer and Brain Metastases.

Journal Article Clin Breast Cancer · December 2023 The treatment of metastatic breast cancer (MBC) has improved over the past decade, however prognosis continues to be mitigated by the fact that about 1 in 5 patients with MBC will develop brain metastases (BrM) during their metastatic disease course. 1 Thi ... Full text Link to item Cite

Systemic Therapy Approaches for Breast Cancer Brain and Leptomeningeal Metastases.

Journal Article Curr Treat Options Oncol · October 2022 Brain metastasis arising from breast cancer is associated with a poor prognosis. Various systemic chemotherapy and targeted therapies which are effective against breast cancer often fail to provide benefits against brain metastasis. This is mainly due to l ... Full text Link to item Cite

Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.

Journal Article Breast Cancer Res Treat · July 2019 PURPOSE: Brain metastases (BM) are a complication of advanced breast cancer (BC). Histology of melanoma BM offers prognostic value; however, understanding the microenvironment of breast cancer brain metastases (BCBM) is less characterized. This study repor ... Full text Link to item Cite